Roth MKM Maintains Buy on Bioceres Crop Solutions, Lowers Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Scott Fortune maintains a Buy rating on Bioceres Crop Solutions (NASDAQ:BIOX) but lowers the price target from $15 to $13.
September 11, 2024 | 2:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Roth MKM analyst Scott Fortune continues to recommend buying Bioceres Crop Solutions but has reduced the price target from $15 to $13, indicating a more cautious outlook.
The Buy rating suggests continued confidence in the company's prospects, but the lowered price target reflects a tempered expectation of future performance, likely due to market conditions or company-specific factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100